The final EpCOT oral presentation from @charlies16.bsky.social at #BTS2026 today was related to PTLD - still the most feared post-transplant cancer. Our analysis shows up-to-date incidence/mortality ratios versus the general population and sub-groups at greater risk. @btstransplant.bsky.social

#2 EpCOT oral from @charlies16.bsky.social at #BTS2026 explores cancer after liver tx in Calle-Williams session. Main findings: ❗️Different SIRs for de novo, second primary and cancer recurrence ❗️Elevated SMRs for all post-tx cancer ❗️HCC recurrence risk is 14% @btstransplant.bsky.social

Charlotte Stephens shares work on cancer screening in transplant patients and if they should be screened more often than the general population #btscongress

Delighted to see my Commentary published in the latest issue of #Circulation Journal Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk–Reducing Intervention in Kidney Failure Disagree? Happy to be challenged 💪🏼 #StopCardiacTests Link to issue: www.ahajournals.org/toc/circ/cur...